Page 27 - Contract Development News Today

/PRNewswire/ -- The "Cell and Gene Therapy Biomanufacturing CDMO Market - Focused on AAV - A Global and Regional Analysis: Focus on Phase of Development,...

SEATTLE, August 23, 2023--AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), today announced a capacity update with the addition of three new Grade B cell therapy suites to its Longmont, CO facility.

Partnership will reduce environmental footprint of pressurized metered dose inhalers and accelerate transition to lower greenhouse gas respiratory care. MORRIS PLAINS, N.J. and STOCKHOLM, Aug. 17,...

/PRNewswire/ -- The "Nutraceuticals CDMO Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies...

The Pharmaceutical Contract Development and Manufacturing Organization Market size is estimated at USD 223.41 billion in 2023, and is expected to reach USD...

PolyPeptide Group / Key word(s): Half Year Results Transformational progress taking shape, profitability impacted by rapid expans...

PolyPeptide Group Key word Half Year Results Transformational progress taking shape profitability impacted by rapid expansion – appointment of Marc Augustin as new CFO 15Aug2023 0700 CETCEST Release

EconoTimes is a fast growing non-partisan source of news and intelligence on global economy and financial markets, providing timely, relevant, and critical insights for market professionals and those who want to make informed investment decisions.

/PRNewswire/ -- The "Global Contract Development & Manufacturing Organization (CDMO) Market: Insights & Forecast (2023-2027)" report has been added to...

Sigma Mostafa is the chief scientific officer of KBI Biopharma, a development and contract manufacturing organization serving the biopharmaceutical industry.